|D009461||Neurologic Manifestations NIH||0.41|
|D000066553||Problem Behavior NIH||0.33|
|D001523||Mental Disorders NIH||0.22|
There is one clinical trial.
Coronavirus disease 2019 (COVID-19), represents a medical and psychological challenge to healthcare workers to the limits that it affects their quality of sleep and their general health.
Description: Pittsburgh sleep quality index (0-21) higher means worse qualityMeasure: measure sleep quality in healthcare worker Time: one month
Description: general health questionnaire (0-12) higher means worseMeasure: impact of covid-19 pandemic on general health Time: 40 days
Description: web based surveyMeasure: correlate between sleep quality and general health Time: 40 days
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports